Clinical Trial 2.0: Can Health 2.0 Transform the FDA Drug Approval Process?

DSpace/Manakin Repository

Clinical Trial 2.0: Can Health 2.0 Transform the FDA Drug Approval Process?

Show simple item record

dc.contributor.advisor Peter Hutt en_US
dc.contributor.author Atanassova, Mira
dc.date.accessioned 2012-06-03T11:47:07Z
dc.date.issued 2011
dc.identifier.citation Mira Atanassova, Clinical Trial 2.0: Can Health 2.0 Transform the FDA Drug Approval Process? (2011). en_US
dc.identifier.uri http://nrs.harvard.edu/urn-3:HUL.InstRepos:8822190
dc.description.abstract Historically, patient activism has played a great part in shaping the drug approval process. Today, aided by developing web technologies, patients are once again seeking increased involvement in their medical care. Their desire to be involved is manifesting in the development of patient-run clinical trials, where patients, with the aid of online health-oriented social networks, are testing the safety and effectiveness of new drugs. While these trials are not currently recognized as valid, scientifically rigorous endeavors and are not accepted by the FDA as evidence of the safety and effectiveness of new drugs, small changes in trial structure can make these patient initiatives a meaningful part of the drug development process. This paper examines the structure and challenges of patient-run clinical trials in the context of the drug development and approval process and suggests an point-of-care design alternative as a way to address the concerns aroused by such patient-led studies. Ultimately, the paper concludes that the enormous social value of such studies should not be ignored, and that the medical, scientific, and regulatory communities should work with patients in helping them designing reliable studies responsive to their needs that can become a meaningful part of the drug development and approval process. en_US
dash.license LAA
dc.subject.other Food and Drug Law en_US
dc.title Clinical Trial 2.0: Can Health 2.0 Transform the FDA Drug Approval Process? en_US
dc.type Paper (for course/seminar/workshop) en_US
dc.date.available 2012-06-03T11:47:07Z

Files in this item

Files Size Format View
Atanasova, Mira - Clinical Trial 2.0.pdf 1010.Kb PDF View/Open

This item appears in the following Collection(s)

Show simple item record

 
 

Search DASH


Advanced Search
 
 

Submitters